Armata Pharmaceuticals, Inc. (ARMP) earnings
ARMP earnings moved a median of -1.96% by the close. Quarterly and annual ARMP reports and results, each read against the price at its own news timestamp. Back to the ARMP overview →
21 measured ARMP earnings events.
Where these ARMP earnings landedvs 19 measured ARMP earnings reactions
| Middle 50% of ARMP earnings reactions | -5.02% to +0.52% |
|---|---|
| Median reaction (to close) | -1.96% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 ARMP earnings events with a measured close landed between -5.02% and +0.52%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Armata Pharmaceuticals Announces Financial Results for the Third Quarter 2026 and Provides Corporate Update | Press release | +0.00% | +0.52% | |
| Form 10-Q Armata Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +0.52% | |
| Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update | Press release | +6.25% | +11.57% | |
| Form 10-Q Armata Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +6.25% | +11.57% | |
| Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update | Press release | -1.49% | -5.75% | |
| Form 10-Q Armata Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.49% | -5.75% | |
| Form 10-K Armata Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.17% | +15.29% | |
| Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update | Press release | -0.36% | — | |
| Form 10-Q Armata Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -0.36% | — | |
| Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update | Press release | +0.00% | -1.96% | |
| Form 10-Q Armata Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.96% | |
| Armata Pharmaceuticals Announces First Quarter 2025 Results and Provides Corporate Update | Press release | — | -1.41% | |
| Form 10-Q Armata Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | — | -1.41% | |
| Form 10-K Armata Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.50% | -10.05% | |
| Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update | Press release | — | -4.29% | |
| Form 10-Q Armata Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | -4.29% | |
| Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update | Press release | — | -9.70% | |
| Form 10-Q Armata Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | — | -9.70% | |
| Armata Pharmaceuticals Announces First Quarter 2024 Results and Provides Corporate Update | Press release | -2.13% | -2.13% | |
| Form 10-Q Armata Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.13% | -2.13% | |
| Form 10-K Armata Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.54% |
Keep exploring
More ARMP: analyst actions → · SEC filings → · ARMP overview →